The latest thoracic oncology news
‘Fluorescent markers’ to illuminate cancer begins Phase 3 clinical trials
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered…
The latest thoracic oncology news
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered…
Jonathan M. Gerber, University of Massachusetts Medical School The American Cancer Society recently reported a…
Tobacco quitlines provide an effective avenue to reach people eligible for lung cancer screening In…
Sam Janes, UCL and Peter Campbell, Wellcome Trust Sanger Institute We know that quitting smoking…
Emergency hospital admission is still the most common route for diagnosing lung cancer in the…
Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk…
GPs are being urged to consider shortness of breath and cough as potential predictors of…
A groundbreaking tumour-highlighting technology – OTL38 – enhances the visualisation of lung cancer tissue, providing…
The Cancer Genetics Group of the Josep Carreras Leukaemia Research Institute, led by Montse Sánchez-Céspedes,…
In the first published study since the market release of robot-assisted bronchoscopy, researchers at Fox…